G GU
Back to Discover Company · English

Guerbet

Guerbet is a global leader in medical imaging, specializing in the development and production of contrast agents used in radiology and interventional imaging. Founded in 1926, Guerbet has a rich history of innovation and commitment to improving patient care through advanced imaging solutions. The company operates in over 100 countries, providing healthcare professionals with the tools necessary for accurate diagnosis and treatment. Guerbet continues to invest in research and development, ensuring that it remains at the forefront of medical imaging technology.

Creation Time:2024-07-22 15 key nodes English

The Timeline

1926 — 2024

  1. 1926

    Foundation of Guerbet

    Guerbet was founded in 1926 by Marcel Guerbet in France, initially focusing on the production of x-ray contrast agents. This marked the beginning of a long-standing commitment to innovation in medical imaging.
  2. 1930

    Launch of First Contrast Agent

    Guerbet introduced its first contrast agent, which was used for radiological examinations, setting a standard for quality and safety in medical imaging.
  3. 1960

    Expansion into International Markets

    Guerbet began its international expansion, establishing a presence in various countries to distribute its contrast agents, thereby increasing its global footprint in the medical imaging sector.
  4. 1970

    Introduction of New Technologies

    Guerbet invested in research and development, leading to the introduction of new technologies in contrast media, enhancing the safety and effectiveness of imaging procedures.
  5. 1992

    Acquisition of Iodine-Based Contrast Agents

    Guerbet acquired the rights to several iodine-based contrast agents, expanding its product portfolio and solidifying its position in the market.
  6. 1998

    Launch of Gadovist®

    Guerbet launched Gadovist®, a gadolinium-based contrast agent for MRI, which became a key product in its imaging portfolio, known for its high safety profile and effectiveness.
  7. 2000

    Establishment of Guerbet Research Institute

    Guerbet established the Guerbet Research Institute to foster innovation and research in the field of medical imaging, focusing on developing new contrast agents and technologies.
  8. 2005

    Acquisition of the Contrast Agent Division of Mallinckrodt

    Guerbet acquired the contrast agent division of Mallinckrodt, significantly enhancing its product offerings and market presence in North America.
  9. 2010

    Launch of Contrast Agents for Interventional Imaging

    Guerbet expanded its product line to include contrast agents specifically designed for interventional imaging, addressing the growing needs of healthcare professionals in this area.
  10. 2014

    Acquisition of the German Company, Bracco Imaging S.p.A.'s Products

    Guerbet acquired specific product lines from Bracco Imaging, further strengthening its position in the global market for contrast agents.
  11. 2018

    Introduction of the New Digital Solutions Platform

    Guerbet launched a new digital solutions platform aimed at enhancing the workflow of medical imaging departments, integrating advanced technologies for better patient management.
  12. 2020

    Focus on Sustainability Initiatives

    Guerbet implemented sustainability initiatives aimed at reducing the environmental impact of its operations and products, aligning with global health and environmental standards.
  13. 2022

    Launch of New MRI Contrast Agent, Elucirem®

    Guerbet launched Elucirem®, a new MRI contrast agent that offers improved imaging quality and safety, reaffirming its commitment to innovation in contrast media.
  14. 2023

    Expansion of Global Partnerships

    Guerbet expanded its global partnerships with healthcare providers and technology companies to enhance the development and distribution of its imaging solutions.
  15. 2024

    Continued Investment in R&D for Advanced Imaging Technologies

    Guerbet announced increased investments in research and development to explore advanced imaging technologies, focusing on artificial intelligence and machine learning applications in radiology.

Regeneration always requests fresh AI content and uses 1 query.

Download History Timeline

Related reading

Real Madrid History Timeline and Biographies organization · English 11 nodes

Real Madrid

Real Madrid is one of the most successful football clubs in history, known for its rich legacy and numerous titles.

11 nodes English
M MY
Other · English 13 nodes

Medicina y Biotecnología evolu

Medicina y Biotecnología evolu represents an innovative intersection of medical science and biotechnology, focusing on enhancing healthcare through advanced technologies and methodologies. The evolution of this field has profound implications for disease treatment, diagnostics, and the development of new therapies. The timeline of Medicina y Biotecnología evolu highlights critical milestones in research, commercialization, and regulatory advancements, demonstrating the rapid progress made in this dynamic sector over the years. As the industry continues to grow, it promises even greater contributions to human health and scientific understanding.

13 nodes English
A AA
organization · English 13 nodes

AAWSAP

The Advanced Aerospace Weapon System Applications Program (AAWSAP) is a U.S. government initiative aimed at investigating and understanding advanced aerospace technologies and unidentified aerial phenomena. Established in the late 2000s, AAWSAP seeks to explore potential threats posed by these phenomena and contribute to national security by leveraging scientific research and technology. The program has garnered significant attention due to its focus on unexplained aerial sightings and its implications for defense strategies.

13 nodes English